Elafibranor

Elafibranor Impurities

Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR-α/δ) agonist investigated for the treatment of non-alcoholic steatohepatitis (NASH) and metabolic disorders. Its impurity profile includes structurally related analogs, residual solvents, and degradation products. These pharmaceutical impurities can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways involve oxidative breakdown of the heteroaromatic rings, hydrolytic cleavage of amide bonds, and rearrangement of substituents within the scaffold. These impurities may affect the potency, stability, and safety of the the drug. Thus, all impurities must be structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.

Elafibranor EP Impurities

We provide the pharmacopeial and non-pharmacopeial Elafibranor impurity compounds that are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and long-term stability studies. EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.

Elafibranor Related Compounds

Structurally related compounds and synthetic analogs of Elafibranor are included for impurity identification, toxicological qualification, and regulatory submission. These related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. They are essential for understanding the impurity profile and ensuring compliance with regulatory limits.

Elafibranor Impurity Reference Standards

We also supply the Elafibranor impurity reference standards, which are available with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. The EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.